Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thy-Sheng Lin

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Neurology. Genetics|April 12, 2016
Expanding genotype/phenotype of neuromuscular diseases by comprehensive target capture/NGSXia Tian, Wen-Chen Liang, Yanming Feng, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|July 17, 2020
Real-world evidence on the safety and effectiveness of fingolimod in patients with multiple sclerosis from TaiwanChih-Chao Yang, Long-Sun Ro, Nai-Wen Tsai, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|November 21, 2023
Efficacy and safety of iscalimab, a novel anti-CD40 monoclonal antibody, in moderate-to-severe myasthenia gravis: A phase 2 randomized studyBaltazar GomezMancilla, Matthew N Meriggioli, Angela Genge, et al.
Acta Neurologica Taiwanica|April 25, 2026
Taiwan Clinical Practice Guidelines for Myasthenia GravisHsu-Ling Yeh, Che-Cheng Chang, An-Bang Liu, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Neurology. Genetics|April 12, 2016
Expanding genotype/phenotype of neuromuscular diseases by comprehensive target capture/NGSXia Tian, Wen-Chen Liang, Yanming Feng, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|July 17, 2020
Real-world evidence on the safety and effectiveness of fingolimod in patients with multiple sclerosis from TaiwanChih-Chao Yang, Long-Sun Ro, Nai-Wen Tsai, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|November 21, 2023
Efficacy and safety of iscalimab, a novel anti-CD40 monoclonal antibody, in moderate-to-severe myasthenia gravis: A phase 2 randomized studyBaltazar GomezMancilla, Matthew N Meriggioli, Angela Genge, et al.
Acta Neurologica Taiwanica|April 25, 2026
Taiwan Clinical Practice Guidelines for Myasthenia GravisHsu-Ling Yeh, Che-Cheng Chang, An-Bang Liu, et al.
Pageof 2